期刊文献+

肝癌细胞微小RNA-100对细胞有丝分裂的影响 被引量:2

Eect of microRNA-100 on mitosis in hepatocellular carcinoma cells
原文传递
导出
摘要 目的:探讨微小RNA(micro RNA-100,miR-100)对人肝癌HepG2细胞有丝分裂的影响。方法:采用实时荧光定量PCR法检测HepG2细胞中miR-100和Polo样激酶1(Polo-like kinase1,Plk1)mRNA的相对表达水平。以脂质体介导的方法将化学合成的带有Cy3荧光标记的miR-100模拟物瞬时转染至HepG2细胞,采用FCM法检测磷酸化组蛋白H3(phospho histone H3,PHH3)标志的转染后细胞的有丝分裂指数,光学显微镜观察细胞的有丝分裂情况,免疫细胞化学法分析转染后细胞中Plk1蛋白表达的变化。结果:同正常肝细胞比较,肝癌HepG2细胞的miR-100水平降低(P<0.05),而Plk1mRNA水平明显升高(P<0.01)。在转染miR-100模拟物48h后,显微镜下可见有丝分裂细胞数较对照组明显减少,且细胞有丝分裂指数明显低于对照组细胞[(0.62±0.48)%vs(10.34±0.77)%,P<0.01]。同对照组相比,miR-100转染组细胞中Plk1mRNA水平在转染后48h时显著降低(P<0.01),且有丝分裂中晚期和末期位于细胞核内的Plk1蛋白基本消失。结论:肝癌细胞中miR-100水平升高可导致细胞有丝分裂阻滞,这可能与细胞核内Plk1蛋白缺失密切相关。 Objective: To investigate the effect of miR-100 (microRNA-100) on mitosis of human hepatoma HepG2 cells. Methods: The relative levels of miR-100 and Plk1 (Polo-like kinase 1) mRNA in HepG2 cells were detected by RFQ-PCR (real-time fluorescence quantitative PCR). Then the HepG2 cells were transiently transfected with liposomes retaining miR-100 mimic which was chemically synthesized and labeled with Cy3 fluorescent marker. After transfection, the activity of mitosis was observed by microscopy and detected by FCM (flow cytometry) using PPH3 (phosphohistone H3) antibody. Moreover, the expression of Plk1 protein was examined by ICC (immunocytochemistry). Results: As compared with the normal hepatocytes, the miR-100 level was decreased in HepG2 cells (P 〈 0.05), but the expression of Plk1 mRNA was increased (P 〈 0.01). At 48 h after transfection of miR-100 mimic, the number of mitotic cells in the experimental group was significantly reduced comparing with that of in the control group (P 〈 0.01), and the mitotic index of the experimental group was significantly reduced comparing with that of the untransfected control group [(0.62 ± 0.48)% vs (10.34 ± 0.77)%, P 〈 0.01]. The expression level of Plk1 mRNA in HepG2 cells was significantly reduced at 48 h after transfection with miR-100 comparing with those of the other groups (P 〈 0.01),and the Plk1 protein locating in the nucleus almost disappeared in metaphase, anaphase, and telophase of mitosis. Conclusion: The increased level of miR-100 can lead to mitotic block in hepatoma cells, which may be closely associated with the loss of Plk1 protein expression in nucleus.
出处 《肿瘤》 CAS CSCD 北大核心 2013年第7期592-596,共5页 Tumor
基金 河南省杰出青年科学基金资助项目(编号:0512000800)
关键词 肝肿瘤 微RNAS 有丝分裂 蛋白质丝氨酸苏氨酸激酶 miR-100 POLO样激酶1 Liver neoplasms MicroRNAs Mitosis Protein-serine-threonine Kinases miR-100 PIR1
  • 相关文献

参考文献13

  • 1LEITE K R, TOMIYAMA A, REIS S T, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer[J]. J Urol, 2011, 185(3): 1118-1122.
  • 2PENG D X, LUO M, QIU L W, et al. Prognostic implications of microRNA- 100 and its functional roles in human epithelial ovarian cancer[J]. Oncol Rep, 2012, 27(4):1238-1244.
  • 3邸菁,柏树令,张凌志,高杰,佟浩.Polo样激酶1在大鼠心肌细胞分化过程中的表达[J].解剖学报,2008,39(4):578-581. 被引量:3
  • 4PELLEGRINO R, CALVISI D F, LADU S, et al. Oncogenic and tumor suppressive roles of polo?like kinases in human hepatocellular carclnornalll. Hepatology, 2010,51(3):857-868.
  • 5HE Z, WU J, DANG H, et al. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of survivin expresslon[J]. Cancer Lett, 2011, 303(2):92-98.
  • 6HAN D P, ZHU Q L, CUI J T, et al. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cellslll. Med Sci Monit, 2012, 18(6):BR237-246.
  • 7LERA R F, BURKARD M E. High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells[J]. J Biol Chern, 2012, 287(51):42812-42825.
  • 8DE OLIVEIRA J C, BRASSESCO M S, PEZUK J A, et al. In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cetls[J]. J Drugs Derrnatol, 2012, 11 (5):5875-5892.
  • 9REAGAN-SHAW S, AHMAD N. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancerlll. FASEBJ, 2005, 19(6):611-613.
  • 10LI B H, ZHOU J S, Y E F, et al. Reduced miR-100 expression in cervical cancer and precursors and its carci nogen ic effect through targeting PLK 1 protelnlll, Eur) Cancer, 2011,47(14):2166-2174.

二级参考文献10

  • 1Anversa P, Leri A, Kajstura J. Cardiac regeneration[J]. J Am Coil Cardiol, 2006, 47(9): 1769-1776.
  • 2Anversa P, Kajstura J, Leri A, et al. Life and death of cardiac stem cells: a paradigm shift in cardiac hiology[J]. Circulation, 2006, 113(11): 1451-1463.
  • 3Nigg EA. Polo-like kinases: positive regulators of cell division from start to finish[J]. Curr Opin Cell Biol, 1998, 10(6) :776-783.
  • 4Reagan-Shaw S, Ahmad N. Polo-like kinase (plk) 1 as a target for prostate cancer managemen[J]. IUBMB Life, 2005, 57(10) :677-682.
  • 5Syed N, Smith P, Sullivan A, et al. Transcriptional silencing of Pololike kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies [J]. Blood, 2006, 107(1) :250-256.
  • 6Van-vugt MA, Bras A, Medema RH. Polo-like Kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells[J]. Mol Cell, 2004, 15(5) :799-811.
  • 7Georgescu SP, Komuro 1, Hiroi Y, et al. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocfles[ J]. J Mol Cell Cardiol, 1997, 29(3) :929-937.
  • 8Mclnnes C, Mazumdar A, Mezna M, et al. lnhibitors of Polo-like kinase reveal roles in spindle-pole maintenance[J]. Nat Chem Biol, 2006, 2(11) :608-617.
  • 9Strebhardt K. Small molecules keep mitotic kinases in check[J]. ACS Chem Biol, 2006, 1 (11) :683-686.
  • 10Soonpaa MH, Kim KK, Pajak L, et al. Cardiomyocyte DNA synthesis and binucleation during murine development[J]. Am J Physiol, 1996, 271 (5 Pt 2) :2183-2189.

共引文献2

同被引文献22

  • 1Peng DX, Luo M, Qiu LW, et al. Prognostic implications of microR- NA - 100 and its functional roles in human epithelial ovarian eanc- er[ J ]. Oncol Rep ,2012,27 (4) : 1238 - 1244.
  • 2Leite KRM,Tomiyama A, Reis ST, et al. MicroRNA - 100 expres- sion is independently related to biochemical recurrence of prostate cancer[J]. J Urol,2011,185(3) :1118 - 1122.
  • 3Chen P,Zhao X, Ma L. Downregulation of microRNA - I00 corre- lates with tumor progression and poor prognosis in hepatocellular carcinoma [J]. Mol Cell Biochem, 2013,383 ( 1 - 2 ) :49 - 58.
  • 4Sun J, Chen Z,Tan X, et al. MicroRNA - 99a/100 promotes apop- tosis by targeting mTOR in human esophageal squamous cell carci- noma[ J]. Med Oncol,2013,30( 1 ) :1 -9.
  • 5Lamouille S, Derynck R. Cell size and invasion in TGF - - in- duced epithelial to mesenchymal transition is regulated by activa- tion of the roTOR pathway [ J ]. J Cell Biol, 2007,178 (3) :437 - 451.
  • 6Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumorsis associated with clinical features and onco- gene/tumor suppressor gene mutations [ J ]. Hepatology, 2008,47 (6) :1955 - 1963.
  • 7Monlserrat N, Gallardo A,Escuin D, et al. Repression of E - cad- herin by SNAIL,ZEBI,and TWIST in invasive ductal carcinomas of breast : A cooperative effort [ J ]. Hum Patho1,2011,42 ( 1 ) : 103 -110.
  • 8Hurt EM, Saykally JN, Anose BM, et al. Expression of the ZEB1 (delta EF1 ) transcription factor in human: Additional insights [J]. Mol Cell Biochem,2008,318( 1 -2) :89 -99.
  • 9Li D, Liu X, Lin L, et al. MicroRNA -99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma [ J ]. J Biol Chem, 2011,286 : 36677 - 36685.
  • 10Jian Sun, Zhaali Chen,Xiaogang Tan, et al. MicroRNA - 99a/100 promotes apoptosis by targeting mTOR inhuman esophageal squa- mous cell carcinoma[ J ]. Med Onco1,2013 ,30 :411.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部